-
Mashup Score: 23Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update - 23 hour(s) ago
Tisagenlecleucel responses in patients with r/r FL remain highly durable a year after primary analysis; no new safety signals were observed.Low levels of L
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 39CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment - 1 day(s) ago
Pediatric CD371-positive B-cell precursor acute lymphoblastic leukemia shows transient lineage switch and slow early response to treatment.Accurate immunop
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 20Hematopoietic and eosinophil-specific LNK(SH2B3) deficiency promotes eosinophilia and arterial thrombosis - 1 day(s) ago
Eosinophils promote arterial thrombosis in hematopoietic LNK deficiency.Eosinophil LNK is essential in suppression of arterial thrombosis.
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 39Thrombocytosis - 1 day(s) ago
An asymptomatic 55-year-old woman presented with thrombocytosis discovered 2 years earlier. Laboratory testing revealed the following: hemoglobin 13.1 g/dL, red blood cell count 5.04 × 10 9 /L, hematocrit 41.8%, mean corpuscular volume 83 fL, mean corpuscular hemoglobin concentration 31.3 g/dL, leukocytes 10.87 × 10 9 /L (neutrophils 43%, lymphocytes 45%, monocytes 5%, eosinophils 4%), and platelets 513 × 10 9 /L. Serum ferritin levels were low at 8 ng/mL. Physical examination was unremarkable. Serum
Source: ashpublications.orgCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 30Volume 143 Issue 17 | Blood | American Society of Hematology - 2 day(s) ago
Blood | 143 | 17 | April 2024
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 85Ibrutinib in CLL: benefit for all? - 3 day(s) ago
In this issue of Blood, Woyach et al1 report an update of a pivotal phase 3 trial showing the superiority of ibrutinib (Ibr)-based treatments over chemoimm
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 42
A 63-year-old man presented with fever, splenomegaly, hyperferritinemia (10 798 ng/dL), elevated soluble interleukin-2R (6644 pg/mL), anemia (hemoglobin 6.9 g/dL), and thrombocytopenia (42 000/μL). Atypical cells were seen on the blood smear (panel A; Wright-Giemsa stain, 50× objective). Bone marrow aspirate showed large pleomorphic tumor cells with metachromatic granules and hemophagocytosis (panel B; Wright-Giemsa stain, 40× objective). Bone marrow biopsy showed a destructive growth pattern (panel C;
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 82Ibrutinib in CLL: benefit for all? - 3 day(s) ago
In this issue of Blood, Woyach et al1 report an update of a pivotal phase 3 trial showing the superiority of ibrutinib (Ibr)-based treatments over chemoimm
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6REVEAL puts leukocytes into risk stratification - 3 day(s) ago
In this issue of Blood, Gerds et al identified persistent leukocytosis above the upper normal value as a risk factor for thrombosis in polycythemia vera. F
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 17How lipid coating soothes the gut in AML therapy - 3 day(s) ago
In this issue of Blood, Renga et al,1 in elegant experimental mouse models, compared the impact on gut microbiota, fungal colonization, and intestinal muco
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
Tisagenlecleucel responses in patients with r/r FL remain highly durable a year after primary analysis; no new safety signals were observed. https://t.co/2qXDdWWcUh #clinicaltrialsandobservations #lymphoidneoplasia https://t.co/KsAdsitQJN